ALPS Advisors’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-123,896
| Closed | -$2.2M | – | 992 |
|
|
2018
Q3 | $2.2M | Buy |
123,896
+24,136
| +24% | +$429K | 0.01% | 239 |
|
|
2018
Q2 | $1.38M | Buy |
+99,760
| New | +$1.38M | 0.01% | 279 |
|
|
2016
Q2 | – | Sell |
-47,207
| Closed | -$146K | – | 652 |
|
|
2016
Q1 | $146K | Sell |
47,207
-8,089
| -15% | -$25K | ﹤0.01% | 612 |
|
|
2015
Q4 | $222K | Sell |
55,296
-10,334
| -16% | -$41.5K | ﹤0.01% | 671 |
|
|
2015
Q3 | $3.01K | Buy |
65,630
+24,039
| +58% | +$1.1K | ﹤0.01% | 651 |
|
|
2015
Q2 | $216K | Buy |
41,591
+20,839
| +100% | +$108K | ﹤0.01% | 676 |
|
|
2015
Q1 | $130K | Sell |
20,752
-44,910
| -68% | -$281K | ﹤0.01% | 649 |
|
|
2014
Q4 | $413K | Sell |
65,662
-7,438
| -10% | -$46.8K | ﹤0.01% | 528 |
|
|
2014
Q3 | $444K | Buy |
+73,100
| New | +$444K | ﹤0.01% | 579 |
|